Literature DB >> 20347151

CD137 enhances monocyte-ICAM-1 interactions in an E-selectin-dependent manner under flow conditions.

Boon Zhi Quek1, Y C Lim, J H R Lin, T E Tan, J Chan, A Biswas, H Schwarz.   

Abstract

Expression of CD137, a member of the tumor necrosis factor receptor family, is inducible on vascular endothelial cells by proinflammatory stimuli. Its ligand is expressed as a transmembrane protein on the surface of monocytes, and transmits activating signals into monocytes (reverse signaling) inducing monocyte migration. These findings led to the hypothesis that CD137 expression on activated endothelial cells facilitates recruitment of monocytes into inflammatory tissues including atherosclerotic lesions. Data from this study demonstrate that CD137 expression is inducible on endothelial cells by TNF stimulation. Recombinant CD137 protein and CD137 expressed on activated endothelial cells enhance ICAM-1-mediated adhesion of monocytes under defined flow conditions in vitro. CD137 seems not to play a role in tethering of monocytes since this activity is completely E-selectin-dependent. In addition, LFA-1 affinity and clustering on monocytic cells is enhanced by CD137. In summary, CD137 expression is induced on vascular endothelial cells by proinflammatory mediators and strengthens ICAM-1 and LFA-1-mediated adhesion of monocytes. These data support a role for CD137 in the recruitment of monocytes to inflammatory tissues. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20347151     DOI: 10.1016/j.molimm.2009.11.010

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  12 in total

Review 1.  CD137 and CD137L signals are main drivers of type 1, cell-mediated immune responses.

Authors:  Bhushan Dharmadhikari; Meihui Wu; Nur Sharalyn Abdullah; Sakthi Rajendran; Nur Diana Ishak; Emily Nickles; Zulkarnain Harfuddin; Herbert Schwarz
Journal:  Oncoimmunology       Date:  2015-11-11       Impact factor: 8.110

2.  CD137L-stimulated dendritic cells are more potent than conventional dendritic cells at eliciting cytotoxic T-cell responses.

Authors:  Zulkarnain Harfuddin; Shaqireen Kwajah; Adrian Chong Nyi Sim; Paul Anthony Macary; Herbert Schwarz
Journal:  Oncoimmunology       Date:  2013-11-11       Impact factor: 8.110

3.  Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit.

Authors:  Emily Nickles; Bhushan Dharmadhikari; Li Yating; Robert J Walsh; Liang Piu Koh; Michelle Poon; Lip Kun Tan; Ling-Zhi Wang; Yvonne Ang; Yugarajah Asokumaran; Wan Qin Chong; Yiqing Huang; Kwok Seng Loh; Joshua Tay; Ross Soo; Mickey Koh; Liam Pock Ho; Marieta Chan; Madelaine Niam; Melissa Soh; Yen Hoon Luah; Chwee Ming Lim; Nivashini Kaliaperumal; Veonice B Au; Najwa Binte Said Nasir Talib; Reina Sng; John E Connolly; Boon Cher Goh; Herbert Schwarz
Journal:  Cancer Immunol Immunother       Date:  2021-10-18       Impact factor: 6.968

Review 4.  Costimulatory pathways: physiology and potential therapeutic manipulation in systemic lupus erythematosus.

Authors:  Nien Yee Kow; Anselm Mak
Journal:  Clin Dev Immunol       Date:  2013-07-29

5.  Species difference of CD137 ligand signaling in human and murine monocytes.

Authors:  Qianqiao Tang; Dongsheng Jiang; Zhe Shao; Julia M Martínez Gómez; Herbert Schwarz
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

Review 6.  Is CD137 Ligand (CD137L) Signaling a Fine Tuner of Immune Responses?

Authors:  Byungsuk Kwon
Journal:  Immune Netw       Date:  2015-06-25       Impact factor: 6.303

7.  Loss of intraepidermal nerve fiber density during SIV peripheral neuropathy is mediated by monocyte activation and elevated monocyte chemotactic proteins.

Authors:  Jessica R Lakritz; Jake A Robinson; Michael J Polydefkis; Andrew D Miller; Tricia H Burdo
Journal:  J Neuroinflammation       Date:  2015-12-18       Impact factor: 8.322

Review 8.  Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus.

Authors:  Anselm Mak; Nien Yee Kow
Journal:  Biomed Res Int       Date:  2014-03-26       Impact factor: 3.411

9.  CD137 promotes bone metastasis of breast cancer by enhancing the migration and osteoclast differentiation of monocytes/macrophages.

Authors:  Pengling Jiang; Wenjuan Gao; Tiansi Ma; Rongrong Wang; Yongjun Piao; Xiaoli Dong; Peng Wang; Xuehui Zhang; Yanhua Liu; Weijun Su; Rong Xiang; Jin Zhang; Na Li
Journal:  Theranostics       Date:  2019-05-09       Impact factor: 11.556

10.  CD137 signaling enhances tight junction resistance in intestinal epithelial cells.

Authors:  Veronica Gusti; Kaila M Bennett; David D Lo
Journal:  Physiol Rep       Date:  2014-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.